Case number 2016-1025
Endo Pharmaceuticals Inc. v. Actavis Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 29, 2018 | 76 | Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [532774] [JAB] [Entered: 06/29/2018 11:22 AM] (1) |
| Jun 29, 2018 | 75 | This entry was made in error and has been removed from the docket. Mandate issued to the United States District Court for the Southern District of New York. Service as of this date by the Clerk of Court. [532719] [15-2022, 15-2023, 15-2025, 15-2028, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118]--[Edited 06/29/2018 by JAB to delete entry] [JAB] [Entered: 06/29/2018 10:18 AM] (0) |
| Jun 29, 2018 | 74 | ORDER filed. The dismissal of Grünenthal’s appeals is vacated and the appeals are reinstated. The appeals are remanded to the district court for the limited purpose of its consideration of Grünenthal’s motion for vacatur. The court retains jurisdiction so that any of the parties may seek appellate review by notifying the Clerk of the Court within thirty days of entry of the district court’s decision on remand. Grünenthal’s appeals are held in abeyance pending the resolution of its motion for vacatur by the district court. Grünenthal’s conditional motions [528191-2], [531502-2] and Kashiv’s motion [526538-2] are denied. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [532702] [15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118] [JAB] [Entered: 06/29/2018 09:37 AM] (3) |
| May 16, 2018 | 73 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. The motions [498233-2], [498247-2], [499990-2], and [506995-2] are granted; Appeal Nos. 15-2022, 15-2023, 15-2025, 15-2028, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2047, 15-2049, 15-2059, 15-2060, and 16-1118 are voluntarily dismissed. Appeal Nos. 15-2021, 15-2024, 15-2026, and 15-2031 are dismissed. (Nonprecedential Opinion). (For the Court: Moore, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge). [522062] [15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1060, 16-1117, 16-1118] Vacated-in-part pursuant to the court's order. See Doc. No. [74]. [JAB] [Entered: 05/16/2018 09:51 AM] (28) |
| Oct 5, 2016 | 71 | ORDER filed. The motion [370705-2] is granted. Actavis’s confidential and non-confidential briefs filed on July 29, 2016 in 2016-1025 (ECF Nos. 63 & 64 in 2016-1025 and ECF Nos. 85 & 86 in 2015-2021) will not be transmitted to the merits panel assigned to hear these cases. Service: 10/05/2016 by clerk. [371923] [15-2021, 16-1025] [LMS] [Entered: 10/05/2016 03:03 PM] (2) |
| Aug 4, 2016 | 70 | Note to file: LEAD APPEAL 2015-2021 is consolidated with appeals 2016-1025, -1117. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [356253] [AT] [Entered: 08/04/2016 03:04 PM] (0) |
| Aug 4, 2016 | 69 | CORRECTED ORDER: correcting order [68]. reason(s): correcting parties' appellate designations; 2016-1060, -1118 are added; subparagr. 3). Service as of this date by Clerk of Court. [356237] [16-1025, 16-1117, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1060, 16-1118] [AT] [Entered: 08/04/2016 02:55 PM] (3) |
| Aug 4, 2016 | 68 | ORDER filed reactivating appeals; consolidating appeals (2015-2021, -2022, -2023, -2024, -2025, -2026, -2028, -2031, -2033, -2034, -2035, -2041, -2042, -2046, -2047, -2049, -2059, -2060; 2016-1025, and -1117). The revised official caption is reflected in the order.; The plaintiffs-cross-appellant's brief is due no later than 60 days from the date of filing of this order. Service: 08/04/2016 by clerk. [356104] [15-2021, 15-2022, 15-2023, 15-2024, 15-2025, 15-2026, 15-2028, 15-2031, 15-2033, 15-2034, 15-2035, 15-2041, 15-2042, 15-2046, 15-2047, 15-2049, 15-2059, 15-2060, 16-1025, 16-1117] [NL] [Entered: 08/04/2016 10:35 AM] (0) |
| Aug 3, 2016 | 67 | Entry of appearance for Blake B. Greene as of counsel for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 08/03/2016 by email. [355944] [Blake Greene] [Entered: 08/03/2016 04:00 PM] (2) |
| Aug 3, 2016 | 66 | 6 paper copies of the Confidential Opening Brief [64] received from Appellants Actavis Inc. and Actavis South Atlantic LLC. [355853] [KW] [Entered: 08/03/2016 02:32 PM] (0) |
| Aug 2, 2016 | 65 | 6 paper copies of the Confidential Opening Brief [64] received from Appellants Actavis Inc. and Actavis South Atlantic LLC. [355644] [KW] [Entered: 08/03/2016 08:35 AM] (0) |
| Jul 29, 2016 | 64 | CONFIDENTIAL BRIEF FILED for Appellants Actavis Inc. and Actavis South Atlantic LLC [61]. Number of Pages: 61. Service: 07/29/2016 by US mail. Pursuant to Fed. Cir. R. 28(d)(2)(A) six paper copies should be filed of the confidential version only. [354951] This brief will not be transmitted to the merits panel pursuant to this court's October 5, 2016 order. [71] [AT] [Entered: 08/01/2016 12:48 PM] (0) |
| Jul 29, 2016 | 63 | BRIEF FILED for Appellants Actavis Inc. and Actavis South Atlantic LLC [62]. Number of Pages: 61. Service: 07/29/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the confidential version of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/08/2016. Cross-Appellant Endo Pharmaceuticals Inc. brief is due 09/12/2016. [354949] This brief will not be transmitted to the merits panel pursuant to this court's October 5, 2016 order. [71] [AT] [Entered: 08/01/2016 12:47 PM] (0) |
| Jul 29, 2016 | 62 | TENDERED from Appellants Actavis Inc. and Actavis South Atlantic LLC. Title: OPENING BRIEF. Service: 07/29/2016 by email, clerk. [354806] This brief will not be transmitted to the merits panel pursuant to this court's October 5, 2016 order. [71] [Charles Weiss] [Entered: 07/29/2016 08:28 PM] (0) |
| Jul 29, 2016 | 61 | TENDERED from Appellants Actavis Inc. and Actavis South Atlantic LLC. Title: CONFIDENTIAL OPENING BRIEF Service: 07/29/2016 by email, clerk, US mail. [354805] This brief will not be transmitted to the merits panel pursuant to this court's October 5, 2016 order. [71] [Charles Weiss] [Entered: 07/29/2016 08:22 PM] (0) |
| Jul 22, 2016 | 60 | Letter from Appellants Actavis Inc. and Actavis South Atlantic LLC re Status Report. Service: 07/22/2016 by email. [353115] [Charles Weiss] [Entered: 07/22/2016 05:24 PM] (7) |
| Jul 12, 2016 | 59 | Amended Notice of Appeal for Actavis Inc. and Actavis South Atlantic, LLC. Service: 07/12/2016 by email. [350061] [SJ] [Entered: 07/12/2016 10:24 AM] (40) |
| Jul 11, 2016 | 58 | Letter from Cross-Appellant Endo Pharmaceuticals Inc. Reactivating Appeals and Requesting Consolidation. Service: 07/11/2016 by email. [349746] [Martin Black] [Entered: 07/11/2016 12:40 PM] (5) |
| Jul 7, 2016 | 57 | **TEXT ONLY** ORDER granting motion to extend time to file appellants' principal brief [56] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. Brief due 07/29/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [349072] [SJ] [Entered: 07/07/2016 12:56 PM] (0) |
| Jul 6, 2016 | 56 | MOTION of Appellants Actavis Inc. and Actavis South Atlantic LLC to extend the time to 07/29/2016 to file the appellant/petitioner's principal brief. Response/Opposition is due 07/21/2016 [Consent: unopposed]. Service: 07/06/2016 by email. [348944] [Charles Weiss] [Entered: 07/06/2016 04:33 PM] (4) |
| Jun 1, 2016 | 55 | Amended Notice of Cross-Appeal (to 16-1117) for Endo Pharmaceuticals Inc. Service: 06/01/2016 by email. [340305] [SJ] [Entered: 06/02/2016 01:20 PM] (64) |
| May 16, 2016 | 54 | ORDER filed denying [51] motion to reconsider order filed by Actavis South Atlantic LLC and Actavis Inc. in 16-1025. (Per Curiam). Service: 05/16/2016 by clerk. [335306] [16-1025, 16-1117] [NL] [Entered: 05/16/2016 01:09 PM] (2) |
| May 16, 2016 | 53 | ORDER filed reopening appeal; Actavis’s opening brief is due no later than 60 days from the date of this order. All remaining deadlines are to be calculated in accordance with Federal Circuit Rule 31(a). Service: 05/16/2016 by clerk. [335226] [16-1025, 16-1117] [NL] [Entered: 05/16/2016 11:02 AM] (2) |
| May 13, 2016 | 52 | REPLY of Appellants Actavis Inc. and Actavis South Atlantic LLC to response filed by Cross-Appellant in 16-1025 , Doc. No [44]. Service: 05/13/2016 by email. [335075] [Charles Weiss] [Entered: 05/13/2016 09:55 PM] (25) |
| May 13, 2016 | 51 | MOTION of Appellants Actavis Inc. and Actavis South Atlantic LLC to reconsider court order [50]. Response/Opposition is due 05/26/2016 [Consent: opposed]. Service: 05/13/2016 by email. [335074] [Charles Weiss] [Entered: 05/13/2016 09:51 PM] (5) |
| May 13, 2016 | 50 | ORDER filed denying [26] and [3] motions for emergency stay pending appeal filed by Actavis South Atlantic LLC and Actavis Inc. in 16-1025. (Per Curiam). Service: 05/13/2016 by clerk. [335054] [16-1025, 16-1117] --[Edited 05/20/2016 by clerk - Reason: To correct docket text] [NL] [Entered: 05/13/2016 05:39 PM] (2) |
| May 12, 2016 | 48 | ORDER filed. The motion to clarify [46] is granted to the extent that Endo need not comply with Rule 27(m)(1)(B). Service: 05/12/2016 by clerk. [334667]--[Edited 05/16/2016 by the Clerk AT - Reason: to correct the link to the motion] [LMS] [Entered: 05/12/2016 03:38 PM] (2) |
| May 12, 2016 | 47 | Amended Notice of Appeal (with docket sheet and orders attached) for Actavis Inc. and Actavis South Atlantic, LLC. Service: 05/12/2016 by email. [334476] [SJ] [Entered: 05/12/2016 11:11 AM] (62) |
| May 11, 2016 | 46 | MOTION of Cross-Appellant Endo Pharmaceuticals Inc. to clarify applicability of Federal Circuit Rule 27(m)(1)(B) to Exhibit 27 to Endo's Response to Emergency Motion for Stay. Response/Opposition is due 05/26/2016, to waive confidentiality requirements. Response/Opposition is due 05/26/2016 [Consent: opposed]. Service: 05/11/2016 by email. [334377] [Sharon Gagliardi] [Entered: 05/11/2016 07:20 PM] (7) |
| May 11, 2016 | 45 | Sealed or confidential document received [Response of Plaintiff-Appellee Endo Pharmaceuticals Inc. to Emergency Motion for Stay Pending Appeal] (corresponding to Doc No. [44]) for Cross-Appellant Endo Pharmaceuticals Inc.. Service: 05/11/2016 by email. [334376] [Sharon Gagliardi] [Entered: 05/11/2016 07:11 PM] (0) |
| May 11, 2016 | 44 | RESPONSE of Cross-Appellant Endo Pharmaceuticals Inc. to the motion for emergency stay pending appeal [26] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/11/2016 by email. [334374] [Sharon Gagliardi] [Entered: 05/11/2016 07:04 PM] (156) |
| May 4, 2016 | 38 | Entry of appearance for Howard S. Suh as of counsel for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/04/2016 by email. [332047] [Howard Suh] [Entered: 05/04/2016 10:54 AM] (2) |
| May 4, 2016 | 36 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: APPELLANTS' motion for emergency stay pending appeal Docket No. [26], ERROR: Attorneys appearing on the motion have not entered their appearances in this matter. CORRECTION: The following attorneys must enter their appearances promptly [HOWARD SUH, ERIC YECIES, NICHOLAS CHIARA], or the motion must be re-filed, removing counsels' names. [331915] [AT] [Entered: 05/04/2016 08:20 AM] (0) |
| May 4, 2016 | 37 | Entry of appearance for Eric H. Yecies as of counsel for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/04/2016 by email. [332032] [Eric Yecies] [Entered: 05/04/2016 10:46 AM] (2) |
| May 4, 2016 | 39 | Entry of appearance for Nicholas P. Chiara as of counsel for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/04/2016 by email. [332055] [Nicholas Chiara] [Entered: 05/04/2016 11:02 AM] (2) |
| May 4, 2016 | 40 | Letter from Appellants Actavis Inc. and Actavis South Atlantic LLC re expedited briefing schedule for Emergency Motion for Stay Pending Appeal (D.I. 26).. Service: 05/04/2016 by email. [332198] [Charles Weiss] [Entered: 05/04/2016 02:29 PM] (2) |
| May 4, 2016 | 41 | ORDER filed. Endo is directed to respond to the motion [26] no later than May 11, 2016. Any reply by Actavis is due no later than May 13, 2016. (Per Curiam). Service: 05/04/2016 by clerk. [332233] [LMS] [Entered: 05/04/2016 03:03 PM] (2) |
| May 4, 2016 | 42 | RESPONSE of Cross-Appellant Endo Pharmaceuticals Inc. to the party letter [40] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/04/2016 by email. [332236] [Sharon Gagliardi] [Entered: 05/04/2016 03:05 PM] (2) |
| May 4, 2016 | 43 | RESPONSE of Cross-Appellant Endo Pharmaceuticals Inc. to the party letter [40] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/04/2016 by email. [332248] [Sharon Gagliardi] [Entered: 05/04/2016 03:24 PM] (2) |
| May 3, 2016 | 33 | Sealed or confidential document received [Sealed Exhibits 9-12] (corresponding to Doc No. [28]) for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/03/2016 by email. [331898] [Charles Weiss] [Entered: 05/03/2016 08:35 PM] (0) |
| May 3, 2016 | 34 | Sealed or confidential document received [Sealed Exhibits 13-16] (corresponding to Doc No. [29]) for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/03/2016 by email. [331899]--[EDITED BY THE CLERK 05/04/2016 by AT--to identify the party filers] [Charles Weiss] [Entered: 05/03/2016 08:39 PM] (0) |
| May 3, 2016 | 35 | Sealed or confidential document received [Sealed Exhibit 17-20 ] (corresponding to Doc No. [30]) for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/03/2016 by email. [331900] [Charles Weiss] [Entered: 05/03/2016 08:44 PM] (0) |
| May 3, 2016 | 32 | Sealed or confidential document received [Sealed Exhibits 5 - 8 ] (corresponding to Doc No. [27]) for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 05/03/2016 by email. [331897]--[EDITED BY THE CLERK 05/04/2016 by AT--to identify the party filers] [Charles Weiss] [Entered: 05/03/2016 08:31 PM] (0) |
| May 3, 2016 | 31 | Sealed or confidential document received [Emergency Motion for Stay Pending Appeal - Confidential Version ] (corresponding to Doc No. [26]) for Appellants Actavis Inc. and Actavis South Atlantic LLC . Service: 05/03/2016 by email. [331896]--[EDITED BY THE CLERK 05/04/2016 by AT--to identify the party filers] [Charles Weiss] [Entered: 05/03/2016 08:26 PM] (0) |
| May 3, 2016 | 30 | Additional volumes of motion for emergency stay pending appeal [26] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/03/2016 by email. [331893] [Charles Weiss] [Entered: 05/03/2016 08:08 PM] (90) |
| May 3, 2016 | 29 | Additional volumes of motion for emergency stay pending appeal [26] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/03/2016 by email. [331892] [Charles Weiss] [Entered: 05/03/2016 08:06 PM] (83) |
| May 3, 2016 | 28 | Additional volumes of motion for emergency stay pending appeal [26] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/03/2016 by email. [331891] [Charles Weiss] [Entered: 05/03/2016 08:03 PM] (48) |
| May 3, 2016 | 27 | Additional volumes of motion for emergency stay pending appeal [26] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/03/2016 by email. [331889] [Charles Weiss] [Entered: 05/03/2016 07:54 PM] (162) |
| May 3, 2016 | 26 | MOTION of Appellants Actavis Inc. and Actavis South Atlantic LLC for an emergency stay pending appeal under Rule 8 [Consent: opposed]. Service: 05/03/2016 by email. [331888] [Charles Weiss] [Entered: 05/03/2016 07:49 PM] (213) |
| May 2, 2016 | 25 | RESPONSE of Cross-Appellant Endo Pharmaceuticals Inc. to the party letter [24] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 05/02/2016 by email. [331389] [Sharon Gagliardi] [Entered: 05/02/2016 06:11 PM] (4) |
| May 2, 2016 | 24 | Notice from Appellants Actavis Inc. and Actavis South Atlantic LLC Notice of Reactivation of the Appeal and Impending Request for Emergency Motion.. Service: 05/02/2016 by email. [331201] [Charles Weiss] [Entered: 05/02/2016 02:31 PM] (34) |
| Nov 10, 2015 | 23 | ORDER file deactivating appeals; Within 30 days of the district courts ruling on the last of the three pending motions, the parties are directed to inform this court how they believe these appeals should proceed. Service: 11/10/2015 by clerk. [287558]--[Edited 11/10/2015 by NEL] [NL] [Entered: 11/10/2015 09:26 AM] (2) |
| Oct 26, 2015 | 22 | Official caption revised to add cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [283280] [SJ] [Entered: 10/26/2015 09:10 AM] (0) |
| Oct 26, 2015 | 21 | Note to file: The following cases are associated:16-1025 (lead) with 16-1117 (cross-appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [283278] [16-1025, 16-1117] [SJ] [Entered: 10/26/2015 09:09 AM] (0) |
| Oct 21, 2015 | 20 | Docketing Statement for the Appellee Endo Pharmaceuticals Inc.. Service: 10/21/2015 by email. [282427] [Sharon Gagliardi] [Entered: 10/21/2015 04:30 PM] (4) |
| Oct 21, 2015 | 19 | Certificate of Interest for the Appellee Endo Pharmaceuticals Inc.. Service: 10/21/2015 by email. [282426] [Sharon Gagliardi] [Entered: 10/21/2015 04:29 PM] (3) |
| Oct 21, 2015 | 18 | Docketing Statement for the Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 10/21/2015 by email. [282278] [Charles Weiss] [Entered: 10/21/2015 02:00 PM] (4) |
| Oct 21, 2015 | 17 | Transcript Purchase Order Form for the Appellants Actavis Inc. and Actavis South Atlantic LLC indicating that a transcript is already on file. Service: 10/21/2015 by email. [282275] [Charles Weiss] [Entered: 10/21/2015 01:55 PM] (3) |
| Oct 9, 2015 | 16 | ORDER filed vacating the court's October 7, 2015 order and holding the motion to stay in abeyance. [7]. By: Judge. Service as of this date by Clerk of Court. [279485] [JW] [Entered: 10/09/2015 05:08 PM] (2) |
| Oct 9, 2015 | 15 | RESPONSE of Appellee Endo Pharmaceuticals Inc. to the motion for emergency stay pending appeal [3] filed by Appellants Actavis South Atlantic LLC and Actavis Inc. in 16-1025. Service: 10/09/2015 by email. [279087] [Sharon Gagliardi] [Entered: 10/09/2015 08:19 AM] (8) |
| Oct 8, 2015 | 14 | Certificate of Interest for the Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 10/08/2015 by email. [279064] [Charles Weiss] [Entered: 10/08/2015 06:46 PM] (4) |
| Oct 8, 2015 | 13 | Entry of appearance for Charles A. Weiss as principal counsel for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 10/08/2015 by email. [279062] [Charles Weiss] [Entered: 10/08/2015 06:44 PM] (3) |
| Oct 8, 2015 | 12 | Letter from Appellants Actavis Inc. and Actavis South Atlantic LLC regarding the District Court's Order (dated and filed October 8, 2015), tolling the effective date of the injunction. Service: 10/08/2015 by email. [279012] [Charles Weiss] [Entered: 10/08/2015 04:21 PM] (3) |
| Oct 7, 2015 | 11 | Entry of appearance for Jonathan D. Loeb as of counsel for Appellee Endo Pharmaceuticals Inc.. Service: 10/07/2015 by email. [278566] [Sharon Gagliardi] [Entered: 10/07/2015 04:22 PM] (2) |
| Oct 7, 2015 | 10 | Entry of appearance for Robert D. Rhoad as of counsel for Appellee Endo Pharmaceuticals Inc.. Service: 10/07/2015 by email. [278565] [Sharon Gagliardi] [Entered: 10/07/2015 04:21 PM] (2) |
| Oct 7, 2015 | 9 | Entry of appearance for Sharon K. Gagliardi as of counsel for Appellee Endo Pharmaceuticals Inc.. Service: 10/07/2015 by email. [278563] [Sharon Gagliardi] [Entered: 10/07/2015 04:19 PM] (2) |
| Oct 7, 2015 | 8 | Entry of appearance for Martin J. Black as principal counsel for Appellee Endo Pharmaceuticals Inc.. Service: 10/07/2015 by email. [278560] [Sharon Gagliardi] [Entered: 10/07/2015 04:18 PM] (2) |
| Oct 7, 2015 | 7 | ORDER filed. Endo is directed to respond to the motion [3] no later than 9:00 AM on October 9, 2015. Any reply by Actavis is due no later than 9:00 AM on October 13, 2015. Service: 10/07/2015 by clerk. [278531] [LMS] [Entered: 10/07/2015 03:45 PM] (2) |
| Oct 7, 2015 | 6 | Clerk's Note to the File: EOAs due 10/21/2015; COIs due 10/21/2015; docketing statements due 10/21/2015; Appellants' opening brief due 12/7/2015. [278263] [SJ] [Entered: 10/07/2015 08:45 AM] (0) |
| Oct 7, 2015 | 5 | Official caption revised to amend case consolidation. Appeal 16-1025 is a stand-alone matter. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [278255] [15-2021, 16-1025] [SJ] [Entered: 10/07/2015 08:33 AM] (0) |
| Oct 6, 2015 | 4 | Sealed or confidential document received [Condifential Rule 8 Motion & Exhibits] (corresponding to Doc No. [3]) for Appellants Actavis Inc. and Actavis South Atlantic LLC. Service: 10/06/2015 by US mail. [278251] [SJ] [Entered: 10/07/2015 08:29 AM] (0) |
| Oct 6, 2015 | 3 | MOTION of Appellants Actavis Inc. and Actavis South Atlantic LLC for an emergency stay pending appeal under Rule 8 [Consent: opposed]. Service: 10/06/2015 by US mail. [278248] [SJ] [Entered: 10/07/2015 08:27 AM] (558) |
| Oct 6, 2015 | 2 | This entry was made in error and has been removed from the docket. Note to file: The following cases are associated:15-2021 (lead) with 16-1025 (cross-appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [278211] [15-2021, 16-1025] [SJ] [Entered: 10/06/2015 04:49 PM] (0) |
| Oct 6, 2015 | 1 | Appeal docketed. Received: 10/05/2015. [278210]. [SJ] [Entered: 10/06/2015 04:47 PM] (196) |
